Darifenacin Cyano Pyrrolidine Nitroso Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Darifenacin is used to treat symptoms of an overactive bladder, such as incontinence (loss of bladder control) or a frequent need to urinate. Darifenacin works on the muscles of the bladder to prevent them from causing incontinence. Darifenacin Cyano Pyrrolidine Nitroso Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Darifenacin Cyano Pyrrolidine Nitroso Impurity CAS NO:NA chemically represented as (S)-2-(1-Nitrosopyrrolidin-3-yl)-2,2-diphenylacetonitrile.Synchemia is the leading manufacturing and exporter of Darifenacin Cyano Pyrrolidine Nitroso Impurity .We supply Darifenacin Cyano Pyrrolidine Nitroso Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143794 |
| CAS No | NA |
| Mol.F. | C21H18D5N5O3S |
| Mol.Wt. | 430.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143795 |
| CAS No | 1219794-54-3 |
| Mol.F. | C4D10N2O |
| Mol.Wt. | 112.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143796 |
| CAS No | NA |
| Mol.F. | C8H7F3N4O5S2 |
| Mol.Wt. | 360.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143797 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143798 |
| CAS No | NA |
| Mol.F. | C15H18N2O4 |
| Mol.Wt. | 290.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143799 |
| CAS No | 2639422-25-4 |
| Mol.F. | C10H19N3O |
| Mol.Wt. | 197.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143800 |
| CAS No | NA |
| Mol.F. | C8H14N2O5 |
| Mol.Wt. | 218.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143801 |
| CAS No | NA |
| Mol.F. | C8H15N3O4 |
| Mol.Wt. | 217.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143802 |
| CAS No | NA |
| Mol.F. | C8H14ClN3O3 |
| Mol.Wt. | 235.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143803 |
| CAS No | NA |
| Mol.F. | C17H9D8FN4O5 |
| Mol.Wt. | 384.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143804 |
| CAS No | NA |
| Mol.F. | C34H39N7O7 |
| Mol.Wt. | 657.7 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143805 |
| CAS No | NA |
| Mol.F. | C12H12D5N3O2 |
| Mol.Wt. | 240.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143806 |
| CAS No | NA |
| Mol.F. | C10H19D4N3O3 |
| Mol.Wt. | 237.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143807 |
| CAS No | NA |
| Mol.F. | C10H18D4N4O4 |
| Mol.Wt. | 266.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143808 |
| CAS No | NA |
| Mol.F. | C10H22N215N2O4 |
| Mol.Wt. | 264.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143809 |
| CAS No | NA |
| Mol.F. | C10H23N215NO3 |
| Mol.Wt. | 234.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |